Kensington Capital Acquisition Corp. IV (NYSE:KCAC) announced that it has once again secured an additional PIPE for its business combination with Amprius Technologies, Inc, just days after entering into agreements worth $15.525 million.
Earlier today, Kensington entered into a subscription agreement with AeroVironment for an aggregate of 500,000 PIPE units at a price of $10.00 per PIPE unit, or $5 million. AeroVironmnet is a global leader in multi-domain robotic systems that serves defense, government and commercial customers and is a customer of Amprius.
Following last week’s series of additional capital, the aggregate PIPE units to be sold now stands at 2,052,500 for total gross proceeds of $20.525 million, with all PIPE units having the same terms.
Kensington secured a $2.15 million PIPE just last Friday through certain entities that have previously invested in an affiliate of Amprius. Days prior to that, the SPAC entered into a separate subscription agreement with multiple investors which agreed to purchase an aggregate of 1,337,500 units at $10.00 per unit for a total purchase price of $13.375 million.
The parties expect to use the capital to help offset potential redemptions of the SPAC’s ordinary shares in connection with the proposed merger, and may be used by Kensington to help satisfy the minimum cash condition of $200 million.
All of the PIPE units will consist of one share of Kensington common stock, and one warrant. The PIPE Warrants will also be substantially identical to the existing Kensington public warrants, except that the exercise price of each PIPE Warrant (for all PIPE subscribers) will be $12.50 per share instead of $11.50 per share, which is the exercise price for the existing Kensington public warrants.
Additionally, the average sales price of the New Amprius Common Stock for PIPE investors will need to exceed $20.00 per share instead of $18.00 per share for the existing public warrants for Kensington to be able to redeem the PIPE Warrants. Furthermore, the PIPE Warrants will not be listed on any securities exchange.
Kensington announced its $939 million deal with Amprius on May 12, 2022. Amprius, the Freemont, California-based silicon nanowire battery company manufacturers high-energy and high-power lithium-ion batteries.
Terms Tracker for the Week Ending January 27, 2022 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re coming up on the end of January, the first month of the year, and to-date no new S-1s have been filed. Additionally, the number...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Circle spokesperson denies blaming SEC for failed deal, BuzzFeed CEO says AI-powered content will be part of core business, and FaZe Clan faces possible delisting Circle Spokesperson Denies Blaming SEC for Failed $9 Billion Deal...
Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26. HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change. However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20...
Carbon capture technology has long been talked about, and it is finally in operation with LanzaTech among the pioneers. Its plants are turning potential emissions into clothing, household goods and sustainable fuels. SPAC cash is now also an accelerant in this new process as the company announced a $1.7 billion combination with AMCI II last March. This week, we caught up with...
In this series we’ll be examining successful SPAC deals from the past both in the terms and circumstances of their de-SPAC processes and how they have weathered the storms that have followed after their public listings with research from SPACInsider contributor Anthony Sozzi. Thirty months does not sound like that long, but it’s been a...